| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
22,300 |
13,593 |
$378K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
22,403 |
13,663 |
$269K |
| 99310 |
Prolong nursin fac eval 15m |
1,582 |
1,314 |
$41K |
| 99307 |
|
2,689 |
2,059 |
$23K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
30 |
28 |
$900.00 |
| 99497 |
|
16 |
16 |
$347.63 |
| 4040F |
|
10,914 |
5,618 |
$307.45 |
| G8482 |
Influenza immunization administered or previously received |
14,720 |
7,729 |
$277.04 |
| G0127 |
Trimming of dystrophic nails, any number |
113 |
92 |
$268.07 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
640 |
303 |
$53.83 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
19,400 |
9,907 |
$0.00 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
2,814 |
1,597 |
$0.00 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
29 |
28 |
$0.00 |
| G9707 |
Patient received hospice services any time during the measurement period |
408 |
152 |
$0.00 |
| M0240 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses |
61 |
61 |
$0.00 |